Searchable abstracts of presentations at key conferences in endocrinology
Menopausal hormone therapy and cardiovascular disease: the women's health initiative (WHI) randomized placebo-controlled hormone trials
The Womens Health Initiative (WHI) placebo-controlled trial of conjugated equine estrogens (CEE) plus medroxyprogesterone (MPA) in 16 608 postmenopausal women, aged 5079 at randomization, was stopped after an average of 5.6 years of follow-up, due to increased risks, including increased coronary heart disease (CHD), stroke, and pulmonary embolism (PE), compared to health benefits. The WHI trial of CEE only in 10 739 women with prior hysterectomy, also aged 50...
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more